Healthcare
Live Price
Offline$0.782
+2.22% today
1Y Change
+56.16%
Window
Jun 23, 2025 → Jun 17, 2026
Coverage: 248 bars · Jun 23, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Rani Therapeutics Holdings, Inc. (RANI) is a Healthcare stock with a market cap of $60.00M and listed on NASDAQ. The stock last traded around $0.78 and up 56.2% across the available one-year price window (Jun 23, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of +58.9%, EPS growth of +57.1%, a dividend yield of 0.0%. What stands out right now is revenue +58.9%, EPS +57.1%, free cash flow +47.4% with operating margin -2345.9% and ROIC -80.6%. Valuation already assumes a fairly strong business story at price/sales 37.6. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines RANI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RANI
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
RANI Max Drawdown
-74.21%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for RANI and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.